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1. Introduction 
Plant use in treating diseases is as old as civilization (Fabricant & Farnsworth, 2001) and 
traditional medicines are still a major part of habitual treatments of different maladies 
(Alviano & Alviano, 2009). In recent times and due to historical, cultural, and other reasons, 
folk medicine has taken an important place especially in developing countries where limited 
health services are available. However, the absence of scientific evaluation of medicinal 
plants to validate their use may cause serious adverse effects (Souza et al., 2004). 
Plants are considered as one of the main sources of biologically active materials. Recent 
records reported that medicinal herbs are used by 80% of the people living in rural areas as 
primary healthcare system (Sakarkar & Deshmukh, 2011). It has been estimated that about 
50% of the prescription products in Europe and USA are originating from natural products 
including plants or their derivatives (Cordell, 2002; Newman et al., 2003). Out of the 250,000 
– 500,000 plant species on earth, only 1-10 % have been studied chemically and 
pharmacologically for their potential medicinal value (Verpoote, 2000). In the Middle East 
region 700 species of the identified plants are known for their medicinal values (Azaizeh et 
al., 2006).  
In spite of the recent domination of the synthetic chemistry as a method to discover and 
produce drugs, the potential of bioactive plants or their extracts to provide new and novel 
products for disease treatment and prevention is still enormous (Raskin et al., 2002). 
Compared with chemical synthesis, plant derived natural products represent an attractive 
source of biologically active agents since they are natural and available at affordable prices 
(Ghosh et al., 2008). Also plants derived agents may have different mechanisms than 
conventional drugs, and could be of clinical importance in health care improvement (Eloff et 
al., 1998). Plant materials might be bioactive secondary metabolites that have the potential to 
treat different afflictions. Examples of these compounds include phenols, phenolic 
glycosides, unsaturated lactones, sulphur compounds, saponins, cyanogenic glycosides and 
glucosinolates (Mukherjee et al., 2001; Quiroga et al., 2001). Such plant derived natural 
products are the main focus of many scientists to develop new medication for different 
diseases like cancer and microbial infection.  
Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal 
cells (Karp, 1999). The high mortality rate among cancer patients is an indication of the 
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limited efficiency of the current therapies including radiation, chemotherapy and surgery 
(Xu et al., 2009). Cancer development is a multi-step process including induction of genetic 
instability, abnormal expression of genes, abnormal signal transduction, angiogenesis, 
metastasis, and immune evasion (Boik, 2001). For many years, scientists were searching for 
miracle cures for cancer using chemically synthesized or natural pure compounds.  In the 
last few decades, research has been focused on the use of natural products such as crude 
plant extracts or a combination of different phytochemicals for cancer therapy; this trend is 
based upon: first, the synergistic effect of the different plant metabolites in the crude extract, 
second, is the multiple points of intervention of such extracts (Neergheen, 2009). This is one 
of the many faces of using plants in the quest of controlling different diseases. Another face 
is the use of such plant products in controlling microbial resistance spread. As a result of the 
uncontrolled use of many antibiotics, their efficiency is being threatened by the emergence 
of microbial resistance to existing chemotherapeutic agents (Cowan, 1999; Pareke & Chanda, 
2007). Bacterial strains such as methicilin-resistant Staphylococcus aureus (MRSA), pencillin-
resistant Streptococcus pneumonia (PRSP), and Vancomycin- resistant enterococci (VRE) in 
addition to the development of multidrug-resistant (MDR) bacterial strains (Alanis, 2005) 
are just few examples that made the search for new and novel bioactive substances among 
the first priorities in the search for antitumor, antibacterial, and antifungal substances 
(Ficker et  al., 2005).  
Realizing all the aforementioned, it is clear that there is a pressing need to participate in the 
search for new and novel bioactive agents that would help in providing new avenues in 
fighting diseases and reducing suffering. This chapter will provide information about 
selected plants that have a potential to provide new anticancer and/or antimicrobial agents. 
2. The history of traditional medicine 
For thousands of years and in different parts of the world, medicinal plants have been used 
to treat different diseases (Palombo, 2009). Fossil records documented the use of medicinal 
plants by humans before 60,000 years (Fabricant & Farnsworth, 2001). Nowadays plants 
continue to be the major source of medicine in rural regions of developing countries (Chitme 
et  al., 2003) and it has been estimated that about 80% of  peoples in developing countries are 
still using medicinal plants for their health care ( Kim, 2005).  
The Eastern region of the Mediterranean has been characterized by high inventory of 
medicinal herbs used by local traditional healers to treat different ailments (Azaizeh et al., 
2006). Research on medicinal plant treasures is based on present day and historical systems 
of traditional and local medicine (Al-Qura’n, 2009). During the Ottoman Empire and 
following the Byzantine traditions, hospitals were run by physician who used pharmacists 
to gather medicinal plants and prepare remedies originating from classical Greek and folk 
medicinal practice (Littlewood et al., 2002). 
A comprehensive study on practitioners and herbalist in Palestine revealed that 
approximately 129 plant species are still prescribed to treat different diseases including 
liver, digestive tract, respiratory system, skin, cancer and other diseases (Azaizeh et al., 
2003). On the other hand, the high diversity of plant species in Jordan encouraged many to 
study the distribution and use of medicinal plants in this country. More than 100 herbalists 
were interviewed in an extensive survey for Jordanian medicinal plants indicated the 
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presence of 150 herbal plants used in folkloric medicine (Abu-Irmaileh & Afifi, 2003). 
Seventy nine plant species are still in use in traditional medicine in the Showbak region 
(south of Jordan) while forty six are part of the popular medicine in the Ajloun Heights 
region (north of Jordan) and some of the plants are used in both regions ( Aburjai et  al., 
2007; Al-Qura’n, 2009). Most of the practitioners were not licensed and have no scientific 
information about medicinal plants (Abu-Irmaileh & Afifi, 2003; Azaizeh et al., 2003). 
The diversity of plants in the Mediterranean region is declining, were recent estimates 
reported less than 200-250 plant species are used to treat different ailments in the Arab 
traditional medicine (Said et al., 2002; Abu-Irmaileh & Afifi, 2003; Saad et al., 2005), 
compared to more than 700 species which were identified for their medicinal uses in 
previous decades (Azaizeh et al., 2006). The high rate of plant extinction on the earth 
necessitates an increase in the efforts to study plant natural products for their potential to 
provide treatment for different afflictions.  
3. Cancer biology  
DNA damage causes conversion of normal cell into a cancer cell. Cancer cells lack the ability 
to communicate with their neighboring cells. The first cancer cell starts to divide producing 
daughter cells, which in turn divide to produce more and more cancer cells. As cancer cells 
divide, they develop malignant characteristics including metastasis, immune system 
evasion, and induction of blood vessels formation (angiogenesis). Continuous cell division 
of cancer cells lead to the formation of tumors. In solid tumors, blood vessels become 
structurally and functionally abnormal; this abnormality leads to heterogeneous blood flow 
which creates chronically hypoxic and acidic regions in the core of the solid tumor (Brown & 
Wilson, 2004). These hypoxic regions lead to the activation of angiogenesis and cell survival 
genes in addition to other genes that induce drug resistant (Chen et al., 2003). Furthermore, 
the low pH microenvironment of cancer cells in the tumor core may prevent the active 
uptake of some anticancer drugs (Mahoney et al., 2003). 
The two traditional therapies (chemotherapy and radiation) are not greatly efficient in 
treating hypoxic cancer cells (Tannock et al., 1998). The killing effect of ionizing radiation 
depends on the presence of oxygen which is absent or very low in the tumor core and the 
poor vascularization minimizes the delivery of chemotherapeutic agents (Brown & Wilson, 
2004). This makes the poorly vascularized regions of tumors a major obstacle to effective 
treatment and opens the door to other therapies that may use different mechanisms to 
targets highly resistant cancer cells. 
4. Oncogenes and tumor suppressor genes 
Two sets of genes are controlling cancer development. Oncogenes are the first set of genes 
and are involved in different cell activities including cell division. However, overexpression 
of these genes transforms a normal cell into a cancer cell. On the other hand, the second set 
of genes (tumor suppressor genes) inhibits cancer cell formation by different mechanisms. 
Tumor suppressor genes are underexpressed in cancer cells while, oncogenes are 
overexpressed. Table 1 summarizes the main oncogenes and tumor suppressor genes and 
their role in cancer development. Oncogenes and their products represent good targets for 
cancer therapy. Other targets include enzymes involved in cell division like topoisomerases 
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that unwind the DNA during replication. The diversity of plant derived natural products 
can provide therapeutic products attacking different targets in cancer cells. 
 
Oncogenes  Functions of their proteins 
Bcl-2 Inhibits apoptosis and protect cancer cell from 
free radicals. 
c-myc Initiate cell division and inhibits differentiation. 
HER-2/neu( c-erb-2) Facilitates signal transduction, expressed in 33% 
of breast cancers. 
MDM2 Protect cancer cells from apoptosis by binding 
and inhibiting p53 (tumor suppressor gene that 
induces apoptosis in damaged cells). 
ras  Facilitate tumor invasion by stimulation of 
collagenase production and inhibits apoptosis by 
increasing MDM2 expression. 
fos and jun Promote uncontrolled proliferation by their 
participation in cell cycle initiation. 
Tumor suppressor genes Functions of their proteins 
Bax An inducer of apoptosis 
Cx32, Cx 43 and other connexin 
producing genes 
Inhibits carcinogenesis by restoring 
communication between cells through gap 
junctions. 
p53 Initiates DNA repair and induce apoptosis in 
cells that cannot be repaired. 
Reference: Boik, 2001 
Table 1. The main oncogenes and tumor suppressor genes. 
5. The use of plants in cancer therapy 
Cancer is one of the major causes of death and the number of cancer patients is in continuous 
rise. Every year 2-3 % of deaths recorded world wide arise from different types of cancer 
(Madhuri & Pandey, 2009). The available treatment methods include surgery, chemotherapy, 
and radiation (Tannock et al., 1998). The increasing costs of conventional treatments 
(chemotherapy and radiation) and the lack of effective drugs to cure solid tumors encouraged 
people in different countries to depend more on folk medicine which is rooted in medicinal 
plants use (Wood-Sheldon et al., 1997). Such plants have an almost unlimited capacity to 
produce substances that attract researchers in the quest for new and novel chemotherapeutics 
(Reed & Pellecchia, 2005).  Although some plant products are used in cancer therapy, plant 
derived anticancer agents represent only one-fourth of the total treatments options. Since 1961, 
nine compounds originating from plants have been approved for use in cancer therapy in the 
United States. These agents are vinblastine, vincristine, navelbine, etoposide, teniposide, taxol, 
taxotere, topotecan, and irinotecan (Lee, 1999). In an extensive study, the anticancer properties 
of 187 plant species were evaluated. Among them, only 15 species have been used to treat 
cancer clinically (Kintzios, 2006). It was observed that different plants contain different 
bioactive compounds and these vary with area, climate and mode of agricultural practice if 
they are not present in wild environment. 
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Herbivory, pathogens and competition are the driving forces that induce plant species to 
develop chemical defense compounds. These plant origin compounds are good models for 
elucidation of their functional roles in medication and treatment of different afflictions 
(Wood-Sheldon et al., 1997). For example, the lignin in the roots of Anthriscus sylvestris 
showed an insecticidal activity (Kozawa et al., 1982). Poisonous plants exposed to frequent 
grazing by animals are commonly rich in alkaloids which have many biological activities 
including anticancer potential (Kintzios, 2006). However, the growth regulatory properties 
of some plant metabolites allow them to act as chemotherapeutical agents. Flavonoids from 
Scutellaria baicalensis act on cyclin-dependent kinases to inhibit cancer cell proliferation (Dai 
& Grant, 2003; Chang et al., 2004). 
Thirteen distinct groups of plant-derived natural products with antitumor properties were 
documented (Kintzios, 2006). Among them, alkaloids (Facchini, 2001), phenylpropanoids 
(Dixon & Paiva, 1995) and terpenoids (Trapp & Croteau, 2001) are well known for their 
antitumor potentials. 
An integrated part of cancer cell development is the resistance to programmed cell death 
(apoptosis). Re-establishment of apoptosis in cancer cells is a target mechanism for 
anticancer agents (Joshi et al., 1999). Some plant-derived products are known to selectively 
induce apoptosis in cancer cells, which represent the ideal property for successful anticancer 
agents (Hirano et al., 1995). Identifying the mode of action of anticancer agents of plant 
origin provide helpful information for their future use. Thus it is important to screen the 
apoptotic potential of plants either in their crude extract form or as pure compounds 
(Tarapadar et al., 2001). Due to their multiple intervention strategies, crude plant extracts 
have been proposed to prevent, arrest, or reverse the cellular and molecular processes of 
carcinogenesis (Neergheen et al., 2009). 
Since the distribution of bioactive compounds differs according to the plant used, different 
solvents were used to extract these compounds from different plants. The methanol extract 
of Scutellaria orientalis showed potent anti-leukemic activity against HL-60 cell line (Ozmen 
et al., 2010). The water extract of Rheum officinale exhibited significant antiproliferative 
activity by inducing apoptosis in MCF-7 and A549 cell lines (Li et al., 2009). A potent 
antiproliferative activity was also reported for the hexane extract of Casearia sylvestris stem 
bark against different cancer cell lines (Mesquita  et  al., 2009) and the butanol extract of 
Pfuffia paniculata demonstrated high cytotoxic activity against MCF-7 cell line (Nagamine et  
al., 2009). Additionally, the Physalis minima chloroform extract induced apoptosis in human 
lung adenocarcinoma cell line (Leong et al., 2009). Out of 76 Jordanian plant species, the 
ethanolic extracts of Inula graveolens, Salvia dominica, Conyza canadiensis and Achillea santolina 
showed potent antiproliferative activity against MCF-7 cell line (Abu-Dahab &Afifi, 2007). 
The aqueous methanol of Ononis hirta and Inula visocsa showed high ability to selectively 
target MCF-7 cancer cells and induced apoptosis (Talib & Mahasneh, 2010a). 
A substantial progress has been made in the treatment of cancer since the early years of 
anticancer drug research. An example of successful anticancer plant products are the vinca 
alkaloids which were isolated from Catharanthus roseus. The first identified vinca alkaloids 
were Vincristine and Vinblastine (Duflos et al., 2002). The antitumor activities of these 
compounds involve binding to tubulin and disruption of mitotic spindle assembly (Nobili et 
al., 2009). Myelosuppression and neurotoxicity were reported as side effects of vinca 
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alkaloids (Yun-San et al., 2008). Another example of plant products in cancer therapy is taxol 
which was extracted from the bark of Taxus brevifolia (Wani et al., 1971). Its cytotoxic activity 
is mediated by stabilizing microtubules rather than destabilizing them (Horwitz et al., 1993). 
Since taxol drugs have low solubility, they are administered together with solvents which 
cause some adverse effects like hypersensitivity and neuropathies (Onetto et al., 1993). 
Other anticancer plant products mediate their activities by inhibiting the enzyme DNA 
topoisomerase. Plants under this category include camptothecins extracted from the Chinese 
tree Camptotheca acuminate (Wall et al., 1966) and Podophyllotoxins extracted from the roots 
of the Indian plant Podophyllum peltatum (Nobili et al., 2009). 
In spite of the success of previously mentioned anticancer plant products, the development 
of multi-drug resistance in cancer chemotherapy still one of the major problems (Xu et al., 
2009). To avoid this problem, researchers focused on other targets including starving cancer 
cells by targeting the process of angiogenesis (formation of new blood vessels) which 
represent an attractive target since tumors depend on angiogenesis for survival and 
metastasis (Griggs et al., 2001). Some plant derived agents showed promising anti-
angiogenic activity such as stilbene combretsatatin- A4 which was isolated from Combretum 
caffrum (Young & Chaplin, 2004). Another strategy to target multi-drug resistance cancers is 
to use a combination of chemotherapy with other strategies including anaerobic bacteria 
which experimentally showed promising results in targeting solid tumors (Dang et al., 
2001). Many plants exhibited promising anticancer activities (Table 2). Such plants may 
provide compounds that can change the list of drugs available for cancer treatment in the 
future. 
 
Family Species  Compounds  
Anacardiaceae Rhus succedanea Flavones, aldehydes 
Annonaceae Annona chrimola, A. muricata, A. 
senegalensis, 
Annonaceous acetogenins  
A. reticulate, A. squamosa, A. bullata (lactones) 
Goniothalamus gardneri, G. amuyon 
and G. giganteus 
lactones 
Polyathia barnesii Clerodane diterpenes 
Xylopia aromatica Annonaceous acetogenins 
Apiaceae Anthriscus sylvestris Lignans 
Seseli mairei Polyacetylenes 
Apocynaceae Alstonia scholaris R. BR. Extract, indole alkaloids 
Ervatamia divaricata, E. microphylla, 
E. heyneana 
Alkaloids 
Plumeria rubra Alkaloids (iridoids), lignans 
Araliaceae Dendropanax arboreus Oxylipins (linoleic acid 
derivatives) 
Panax ginseng, P. quinquefolius, P. 
vietnamensis 
Saponins, polysaccharides, 
polyacetylenic alcohols 
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Aristolochiaceae Aristolochia elegans, A. versicolar Sesquiterpene lactones 
Asclepiadaceae Calotropis procera, C. gigantea Glycosides 
Asteraceae Neurolaena lobata Sesquiterpene lactones 
Bigoniaceae Kigelia pinnata Dichloromethane extracts 
Burseraceae Bursera simaruba, B. permollis, B. 
morelensis, B. microphylla, B. klugii, B. 
schlechtendalii 
Lignans 
Caesalpiniaceae Caesalpinia sappan Ethyl acetate extracts 
Campanulaceae Platycodon grandiflorum Polysaccharides 
Capparaceae Polanisia dodecandra Flavonols 
Celastraceae Glyptopetalum sclerocarpum Terpenoids 
Maytenus boaria, M. guangsiensis, M. 
ovatus, M. senegalensis, M. 
wallichiana and M. emarginata 
Triterpenes 
Combretaceae Bucida buceras Flavanones, diterpenes 
Terminalia arjuna Flavones, tannins 
Compositae Eupatorium cannabinum Lactones 
E. cuneifolium, E. rotundifolium, E. 
semiserratum, E. altissimum 
Flavones 
Hellenium microcephalum, H. hoopesii Sesquiterpene lactones 
Xanthium strumarium Alkaloids 
Inula viscosa Flvonoids and alkaloids 
Inula graveolens, Achillea santolina, 
Conyza canadiensis 
Ethanol extract 
Conifereae J. virginiana, J. chinensis Podophyllotoxin (lignans) 
Cucurbitaceae Cucurbita moschata, Mormodica 
charantia 
Proteins 
Cupressaceae Chamaecyparis lawsonianna, Thujopsis 
dolabrata 
Alkaloids 
Ericaceae Vaccinium macrocarpon, V. smallii Triterpenes, flavonol, 
glycosides 
Eriocaulaceae Paepalanthus latipes Naphthoquinones 
Euphorbiaceae Emblica offcinalis Aqueous extracts, 
Norsesquiterpenoid, 
glycosides 
Euphorbia amygdaloides, E. helioscopic,
E. lathyris, E. mongolica, E. pubescens 
Jatrophane diterpenoids 
Jatropha curcas, J. macrorhiza Jatrophane diterpenoids and 
triterpenoids 
Mallotus phillipinensis Rottlerin, phloroglucinol 
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derivatives 
Phyllanthus acuminatus, P. amarus, P. 
emblica, P. urinaria 
Glycosides 
Fabaceae Ononis sicula, Ononis hirta Aqueous methanol extract 
Flacourtiaceae Caesaria sylvestris Clerodane diterpenes 
Guttiferae Garcinia hunburyi Processed extract 
Hernandiaceae Hernandia sp. Lignans 
Hyacynthaceae Scilla scilloides, S. peruviana Glycosides 
Hypericaceae Hypericum perforatum, H. drummondii Polycyclic diones 
Iridaceae Crocus sativus Carotenoids 
Lamiaceae Hyptis martiusii, H. verticillata Diterpenes, lignans 
Origanum vulgare, O. majorana Quinines, quinine glycosides 
Rabdosia ternifolia, R. trichocarpa, R. 
macrophylla 
Diterpenoids, lactones 
Salvia sclarea Lectins, Ursolic acid 
(carboxylic acids) 
Salvia pinardi Aqueous methanol extract 
Salvia przewalskii Quinones 
Salvia dominica Ethanol extract 
Scutellaria barbata, S. lateriflora, S. 
baicalensis 
Flavonoids, flavones 
Lauraceae Cinnanomum camphora Cinnamaldehydes 
Leguminosae 
 
Acacia catechu, A. victoriae, A. 
confuse, A. auriculiformis A. Cunn. 
and A. nilotica  
Proteins 
Bauhinia racemosa Methanol extracts 
Cassia acutifolia, C. angustifolia, C. 
torosa, C. leptophylla 
Anathracenes, 
polysaccharides, piperidin 
(alkaloids) 
C. pudibunda Glycyrrhiza glabra, G. 
uralensis, G. inflata 
Anthraquinones Glycyrrhizic 
acid, glycyrrhetinic acid, 
flavonoids and  
Tamarindus indica Triterpenoids, Polysaccharides 
Liliaceae Colchicum autumnale, C. speciosum
Crinum asiaticum var. toxicarium 
Alkaloids 
Linaceae Linum usitatissimum Lignans 
 Viscum cruciatum Hexanoic acid extracts 
Magnoliaceae M. offcinalis, M. grandiflora, M. 
virginiana 
Neolignans 
Malvaceae G. herbaceum G., indicum Cathechin (phenolics) 
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Meliaceae Azadirachta indica Limonoids (triterpenes) 
Melia azedarach Limonoids (triterpenes) 
Myrtaceae Eugenia jambos Hydrolyzable tannins 
Ochnaceae Ouratea hexasperma, O. semiserrata Biflavonoids
Pinaceae Pseudolarix kaempferi Triterpene lactones, diterpenes 
Polygalaceae Polygala vulgaris Xanthones
Polygonaceae Polygonum cuspidatum Flavonoids, anthraquinones 
Ranunculaceae Nigella sativa Quinones, fatty acids 
 Pulsatilla koreana Lignans, saponins 
Rosaceae Agrimonia pilosa Tannins, methanolic extracts 
Rubiaceae Nauclea orientalis Angustine alkaloids 
Psychotria. rubra, P. forsteriana Napthoquinones, alkaloids 
Rubia cordifolia, R. akane Cyclic hexapeptides 
Naphthoquinones, 
anthraquinones 
Rutaceae Aegle marmelos Correa Fagara 
macrophylla 
Hydroalcoholic extract 
Alkaloids 
Acronychia oblonga, A. porteri, A. 
pedunculata, A. Baueri
Flavonols, alkaloids 
Zieridium pseudobtusifolium Flavonols
Sapindaceae Koelreuteria henryi Anthraquinone, stilbene, and 
flavonoids
Simaroubaceae Brucea dysenterica, B. javanica Quassinoid glycosides, 
Alkaloids 
Eurycoma harmadiana Alkaloids, quassinoids 
Hannoa chlorantha, H. kleineana Quassinoids, chaparrinones 
Solanaceae Solanum pseudocapsicum Alkaloids
Scrophulariaceae Verbascum sinaiticum Aqueous methanol extract 
Theaceae Camellia sinensis Polyphenols
Thymelaceae Stellera chasmaejasme Diterpenes
Tropaeolaceae Wikstroemia foetida, W. uvaursi, W. 
indica, Tropaeloum majus 
Polysaccharides, Aromatic 
plant hormones 
Umbellifereae Angelica archangelica A. keiskei, A. 
sinensis,A. gigas, A. acutiloba, A. 
radix, A. japonika, A. edulis 
Pyranocoumarins, chalcones, 
polysaccharides 
Urticaceae Ficus carica Lectins
Verbenaceae Vitex rotundifolia Flavonoids
Violaceae Viola odorata Nucleotides
References: (Kintzios, 2006), (Abu-Dahab and Afifi, 2007), (Talib and Mahasneh, 2010) 
Table 2. Plants with potential anticancer activity 
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6. Plants as a source of antimicrobial agents 
The discovery of antibiotics has decreased the spread and severity of a wide variety of 
inferior diseases. However, and as a result of their uncontrolled use, the efficiency of many 
antibiotics is being threatened by the emergence of microbial resistance to existing 
chemotherapeutic agents (Cowan, 1999). While bioactive natural compounds have been 
isolated mainly from cultivable microbial strains, an untapped biologically active 
metabolites of different resources including plants remains to be investigated (Quiroga et 
al., 2001) to alleviate or help responding to current health care situations; such situations 
include but not limited to unmet clinical needs, increasing cost of chemotherapy, 
mycobacterial reemergence, and the emergence of antibiotic resistant microbial strains such 
as MRSA (Alanis et al., 2005) . 
Microbial resistance occurs mainly in three general mechanisms: prevention of interaction of 
the drug with target; direct destruction or modification of the drug; and efflux of the drug 
from the cell (Alviano & Alviano, 2009). These mechanisms were used by different 
microorganisms and led to the emergence of many pathogenic bacterial strains (Alanis et al., 
2005). With pathogenic fungi, the situation is not so bright also, where Amphotericin B was 
for many years the only treatment available for fungal infections. In late 1980s fluconazole 
and itracozole was developed as additional therapeutic options (Ficker et al., 2002). 
Recently, azole derivatives are most widely used antifungal agents, although resistance for 
these drugs is emerging (Groll et al., 1998). All the available antifungal drugs used to date 
are not ideal in efficiency, safety, and antifungal spectrum (Di Domenico, 1998). 
Combination antifungal therapy was also used to increase the efficiency but there is a real 
demand for a next generation of safer and more powerful antifungal agents (Bartoli et al., 
1998). Knowing that modifying known antimicrobial compounds is increasingly difficult 
created an urgent and very pressing need for isolation and identification of new bioactive 
chemicals from new sources including plants (Barker, 2006). 
Plant derived natural products represent an attractive source of antimicrobial agents since 
they are natural, have manageable side effects and available at affordable prices (Ghosh et 
al., 2008). Also plants derived agents may have different mechanisms than conventional 
drugs, and could be of clinical importance in health care improvement (Ellof, 1998).  
There are two main classes of plant derived agents.1) phytoalexins which are low molecular 
weight compounds produced in response to microbial, herbivorous, or environmental 
stimuli (Van Etten et al., 1994). Phytoalexins include simple phenylpropanoid derivatives, 
flavonoids, isoflavonoids, terpenes and polyketides (Grayer & Harbborne, 1994). 2) 
Phytoanticipins which are produced in plants before infection or from pre-existing 
compounds after infection (Van Etten et al., 1994). Phytoanticipins include: glycosides, 
glucosinolates and saponins that are normally stored in the vacuoles of plant cells (Osbourn, 
1996). The antimicrobial potential of plant derived natural products is well documented. 
Schelz and colleagues reported the potential of menthol isolated from peppermint oil to 
eliminate the resistance plasmids of bacteria (Schelz et al., 2006). In another study carbazole 
alkaloids isolated from Clausena anisata stem bark showed high antibacterial and antifungal 
activities (Chakraborty et al., 2003). 
Thousands of other phytochemicals having in vitro antimicrobial activities were also 
screened. Such screening programs are essential for validating the traditional use of 
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medicinal plants and for providing leads in the search for new antimicrobial agents 
(Alviano & Alviano, 2009). A number of studies of the bioactivity of plant extracts have been 
conducted and many of these studies showed promising results in developing new 
biologically active agents. The methanolic extract of clove Caryophyyllus aromaticus showed 
antibacterial activity against many bacterial genera and the highest activity was against 
Staphylococcus aureus (Ushimaru et al., 2007). Association of clove extract and antibiotics 
showed synergistic antibacterial activity against antibiotic resistant Pseudomonas aeruginosa 
(Nascimento et al., 2000). Out of the 50 plants used in Indian traditional medicine, 72% 
showed antimicrobial activity including nine plants showed antifungal activity (Srivnivasan 
et al., 2001). When some Palestinian plants were tested for bioactivity, out of fifteen used in 
traditional medicine, only eight showed antibacterial activity against eight different 
bacterial strains (Essawi & Srour, 2000). Butanol extracts of Rosa damascene, Narcissus tazetta, 
and Inula viscose exhibited potent antimicrobial activities against different microorganism 
including Methicillin-resistant Staphylococcus aureus and Candida albicans (Talib & Mahasneh, 
2010b). 
During the past decade there is an increase in the number of immuno-compromised 
patients. This is probably due to the alteration of the immune system caused by human 
immunodeficiency virus (HIV), cancer chemotherapy, and organ and bone marrow 
transplantation in addition to the use of immune suppressors to treat many diseases 
(Alexander & Perfect, 1997). The compromised immune system facilitates microbial 
infections including systemic mycosis. This leads to extensive use of Amphotericin B and 
azole derivatives as antifungal agents. Unfortunately, the wide range use of these antifungal 
agents leads to the emergence of drug resistant pathogenic fungi (Alexander & Perfect, 
1997). Candida albicans is opportunistic yeast that can cause vaginal, oral, and lung infections 
in addition to systemic tissue damage in AIDS patients (Madigan & Martinko, 2006). This 
yeast was the target of many researchers to develop new antifungal agents. Out of twenty 
four medicinal plants used in traditional medicine in South Africa, two showed high 
potential to treat candidiasis (Motsei et al., 2003). Also some indigenous plants of Lebanon 
showed antimicrobial activity against Candida albicans and other tested microorganisms 
(Barbour et al., 2004).  
 Successive isolation of antimicrobial compounds from plants depends upon the type of 
solvent used in extraction procedure (Parekh & Chanda, 2007). Literature reported the use 
of different solvents to extract antimicrobial agents. The ethanol/methanol extracts of 
thirty four medicinal plants were more active than aqueous extracts against bacterial 
strains belonging to Enterobacteriaceae (Parekh & Chanda, 2007). Methanolic extract of 
Terminallia chebula showed higher antibacterial potential compared with aqueous extract 
(Ghosh et al., 2008). Mahasneh found that butanol extracts of several plants including:  
Lotus halophpilus, Pulicaria gnaphaloides, Capparis spinosa, Medicago laciniata, Limonium 
axillare to exhibit superior antimicrobial activity compared with ethanol and aqueous 
extracts (Mahasneh, 2002). The ethanolic extract of 11 plant species from Argentina 
showed high antimicrobial activity against a list of microorganisms including methicillin, 
oxacillin, and gentamicin resistant Staphylococcus (Zampini et al., 2009). Of 16 plants 
studied, the methanolic and aqueous extracts of 10 Yemeni plants exhibited significant 
antimicrobial activity against three gram positive, two gram negative bacteria, and one 
fungus (Mothana et al., 2009). 
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Jordanian plants were the focus of many researchers for their antimicrobial activities.  
Butanol, ethanol, petroleum ether, and aqueous extracts were prepared from nine Jordanian 
plants. Butanol extract showed superior antimicrobial activity compared with other extracts 
(Mahasneh & El-Oqlah, 1999). Of 27 ethanol extracts prepared from indigenous Jordanian 
plants, six plants showed promising antimicrobial activity against different test 
microorganisms (Al-Bakri & Afifi, 2007). In addition to their broad antimicrobial activities 
some Jordanian plants like Sonchus oleraceus and Laurus nobilis exhibited high antiquorum 
sensing activities (Al-Hussaini & Mahasneh, 2009). Other Jordanian plants like Crupina 
crupinastrum and Achillea biebersteinii showed high antimicrobial activity against bacteria 
and fungi (Khalil et al., 2009). Additionally the methanolic extracts of two Jordanian plants 
Artemisia herba-alba and Artemisia arborescens showed high antibacterial activity against 32 
isolates of Mycoplasma species (Al-Momani et al., 2007). 
7. Conclusions 
The potential isolation and use of new and novel bioactive products from plant origins is 
still very productive playground for the development of new drugs to improve health care 
in certain medical fields. It is essential to emphasize that extensive in vitro and in vivo tests 
must be conducted to assure the selection of active and nontoxic anticancer and 
antimicrobial phytochemicals. 
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